超声内镜与磁共振胰胆管成像引导内镜逆行胰胆管造影在中度可能胆总管结石患者中的比较:一项随机对照试验
该单中心随机对照试验纳入224例符合ESGE指南中度可能胆总管结石的患者,随机分入超声内镜(EUS)组或磁共振胰胆管成像(MRCP)组,以ERCP或随访为金标准比较诊断准确性。两组敏感性均高(92%-98%)且无显著差异,EUS组阴性预测值和阳性似然比显著更高(p<0.05)。结论认为两种检查性能相当,选择应基于本地专长、资源可及性和患者偏好。
要点
- EUS与MRCP诊断胆总管结石的敏感性均高(92%-98%),两组间无显著差异。
- EUS组阴性预测值和阳性似然比显著高于MRCP组(p<0.05)。
- 两组因假阴性漏诊(EUS 2例 vs MRCP 5例)或假阳性不必要ERCP(EUS 1例 vs MRCP 2例)均少。
核心结论
- EUS与MRCP在中度可能胆总管结石患者中检测胆总管结石的性能参数相当。
- 检查选择应基于本地专长、资源可及性和患者偏好。
研究设计与样本
- 单中心随机对照试验,于2019年11月至2020年5月筛选符合ESGE指南中度可能胆总管结石的患者。
- 共纳入224例患者(平均年龄46.77±14.57岁;女性50.9%),随机分入EUS组或MRCP组。
- 结石阳性者或随访期间持续临床怀疑者行ERCP,阴性者进一步行6个月临床随访。
- 主要结局为两种检查诊断胆总管结石的准确性(敏感性/特异性),以ERCP或随访为金标准。
主要发现
- 总体胆总管结石患病率为49.6%,MRCP组频率更高(MRCP组63/112 vs EUS组46/112)。
- EUS与MRCP的敏感性均高(92%-98%),两组间无显著差异。
- EUS组阴性预测值和阳性似然比显著高于MRCP组(p<0.05)。
- 假阴性(漏诊)EUS组2例 vs MRCP组5例;假阳性(不必要ERCP)EUS组1例 vs MRCP组2例,两组均低。
关键数值与推荐
- ESGE指南推荐:对中度可能胆总管结石患者,使用EUS或MRCP诊断胆总管结石以确定ERCP治疗指征。
临床怎么用
- 原文结论认为EUS与MRCP性能相当,检查选择应基于本地专长、资源可及性和患者偏好。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: In patients with an intermediate likelihood of choledocholithiasis, European Society of Gastrointestinal Endoscopy (ESGE) guidelines recommend endoscopic ultrasound (EUS) or magnetic resonance cholangiopancreatography (MRCP) to diagnose choledocholithiasis to make the indication for endoscopic retrograde cholangiopancreatography (ERCP) treatment; there is no randomised control trial to compare both in this setting. DESIGN: Patients with suspected choledocholithiasis satisfying ESGE guideline's intermediate likelihood were screened for this single-centre randomised controlled trial between November 2019 and May 2020. The enrolled patients were randomised to either EUS or MRCP. ERCP was performed in stone positive cases or if clinical suspicion persisted during follow-up. Negative cases underwent a further 6-month clinical follow-up. Main outcome was accuracy (sensitivity/specificity) of both tests to diagnose choledocholithiasis, with ERCP or follow-up as a gold standard. RESULTS: Of 266 patients, 224 patients (mean age: 46.77±14.57 years; 50.9 % female) were enrolled; overall prevalence of choledocholithiasis was 49.6%, with a higher frequency in the MRCP group (63/112 vs 46/112 for EUS). Both sensitivity of EUS and MRCP were similarly high (92%-98%), without significant differences between the two groups. The negative predictive value and likelihood ratio + were significantly higher in EUS arm (p<0.05). The percentage of ERCPs either incorrectly halted back (false negatives: EUS: 2 vs MRCP: 5) or performed unnecessarily (false positives: EUS: 1 vs MRCP: 2) was low in both groups. CONCLUSION: The performance parameters of both EUS and MRCP are comparable for detecting choledocholithiasis in the intermediate-risk group of choledocholithiasis and the choice of a test should be based on local expertise, availability of resources and patient preference. TRIAL REGISTRATION NUMBER: NCT04173624.
引用
- Jagtap N, Kumar JK, Chavan R, et al. EUS versus MRCP to perform ERCP in patients with intermediate likelihood of choledocholithiasis: a randomised controlled trial. Gut. 2022. PMID: 35144973. doi:10.1136/gutjnl-2021-325080
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。